Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 122

1.

Drug eluting balloon for the treatment of patients with coronary artery disease: Current perspectives.

Lunardi M, Zivelonghi C, van den Brink FS, Ghione M, Vinco G, Benfari G, Scarsini R, Ribichini F, Agostoni P.

Cardiovasc Revasc Med. 2018 Mar;19(2):215-220. doi: 10.1016/j.carrev.2017.09.002. Epub 2017 Sep 10. Review.

PMID:
29066340
2.

Drug-coated balloon: Long-term outcome from a real world three-center experience.

Zivelonghi C, Ghione M, Benfari G, Cuman M, Fede A, Lunardi M, Cordone S, Botta M, Pacchioni A, Bellone P, Reimers B, Ribichini FL.

J Interv Cardiol. 2017 Aug;30(4):318-324. doi: 10.1111/joic.12391. Epub 2017 Jun 5.

PMID:
28580767
3.

Ajmaline Challenge To Unmask Infrahisian Disease In Patients With Recurrent And Unexplained Syncope, Preserved Ejection Fraction, With Or Without Conduction Abnormalities On Surface ECG.

Pentimalli F, Bacino L, Ghione M, Giambattista S, Gazzarata M, Bellotti P.

J Atr Fibrillation. 2016 Aug 31;9(2):1421. doi: 10.4022/jafib.1421. eCollection 2016 Aug-Sep.

4.

Five-year outcomes of chronic total occlusion treatment with a biolimus A9-eluting biodegradable polymer stent versus a sirolimus-eluting permanent polymer stent in the LEADERS all-comers trial.

Ghione M, Wykrzykowska JJ, Windecker S, Serruys PW, Buszman P, Linke A, Sohn HY, Corti R, Antoni D, Wijns W, Estevez-Loureiro R, Morice MC, Van Es GA, van Geuns RJ, Juni P, Eerdmans P, De Vries T, Konik S, Di Mario C.

Cardiol J. 2016;23(6):626-636. doi: 10.5603/CJ.a2016.0071. Epub 2016 Sep 26.

5.

Absorb vs. DESolve: an optical coherence tomography comparison of acute mechanical performances.

Mattesini A, Boeder N, Valente S, Löblich K, Dörr O, Secco GG, Foin N, Caiazzo G, Ghione M, Gensini GF, Porto I, Di Mario C, Nef H.

EuroIntervention. 2016 Aug 5;12(5):e566-73. doi: 10.4244/EIJV12I5A96.

6.

Effect of advanced chronic kidney disease in clinical and echocardiographic outcomes of patients treated with MitraClip system.

Estévez-Loureiro R, Settergren M, Pighi M, Winter R, D'Allara G, Jacobsen P, Sondergaard L, Cheung G, Ghione M, Ihlemann N, Moat NE, Price S, Rosenberg TS, Di Mario C, Franzen O.

Int J Cardiol. 2015 Nov 1;198:75-80. doi: 10.1016/j.ijcard.2015.06.137. Epub 2015 Jul 2.

PMID:
26156318
7.

Very high-pressure dilatation for undilatable coronary lesions: indications and results with a new dedicated balloon.

Secco GG, Ghione M, Mattesini A, Dall'Ara G, Ghilencea L, Kilickesmez K, De Luca G, Fattori R, Parisi R, Marino PN, Lupi A, Foin N, Di Mario C.

EuroIntervention. 2016 Jun 20;12(3):359-65. doi: 10.4244/EIJY15M06_04.

8.

Effect of gender on results of percutaneous edge-to-edge mitral valve repair with MitraClip system.

Estévez-Loureiro R, Settergren M, Winter R, Jacobsen P, Dall'Ara G, Sondergaard L, Cheung G, Pighi M, Ghione M, Ihlemann N, Moat NE, Price S, Streit Rosenberg T, Di Mario C, Franzen O.

Am J Cardiol. 2015 Jul 15;116(2):275-9. doi: 10.1016/j.amjcard.2015.04.019. Epub 2015 Apr 18.

PMID:
25960377
9.

ABSORB biodegradable stents versus second-generation metal stents: a comparison study of 100 complex lesions treated under OCT guidance.

Mattesini A, Secco GG, Dall'Ara G, Ghione M, Rama-Merchan JC, Lupi A, Viceconte N, Lindsay AC, De Silva R, Foin N, Naganuma T, Valente S, Colombo A, Di Mario C.

JACC Cardiovasc Interv. 2014 Jul;7(7):741-50. doi: 10.1016/j.jcin.2014.01.165.

10.

Intracoronary optical coherence tomography: a review of clinical applications.

Zivelonghi C, Ghione M, Kilickesmez K, Loureiro RE, Foin N, Lindsay A, de Silva R, Ribichini F, Vassanelli C, Di Mario C.

J Cardiovasc Med (Hagerstown). 2014 Jul;15(7):543-53. doi: 10.2459/JCM.0000000000000032. Review.

PMID:
24922045
11.

The role for adjunctive image in pre-procedural assessment and peri-procedural management in chronic total occlusion recanalisation.

Estevez-Loureiro R, Ghione M, Kilickesmez K, Agudo P, Lindsay A, Di Mario C.

Curr Cardiol Rev. 2014 May;10(2):120-6. Review.

12.

Incomplete stent apposition causes high shear flow disturbances and delay in neointimal coverage as a function of strut to wall detachment distance: implications for the management of incomplete stent apposition.

Foin N, Gutiérrez-Chico JL, Nakatani S, Torii R, Bourantas CV, Sen S, Nijjer S, Petraco R, Kousera C, Ghione M, Onuma Y, Garcia-Garcia HM, Francis DP, Wong P, Di Mario C, Davies JE, Serruys PW.

Circ Cardiovasc Interv. 2014 Apr;7(2):180-9. doi: 10.1161/CIRCINTERVENTIONS.113.000931. Epub 2014 Mar 18.

PMID:
24642998
13.

Optical coherence tomography characteristics of in-stent restenosis are different between first and second generation drug eluting stents.

Kilickesmez K, Dall'Ara G, Rama-Merchan JC, Ghione M, Mattesini A, Vinues CM, Konstantinidis N, Pighi M, Estevez-Loureiro R, Zivelonghi C, Lindsay AC, Secco GG, Foin N, De Silva R, Di Mario C.

Int J Cardiol Heart Vessel. 2014 Mar 19;3:68-74. doi: 10.1016/j.ijchv.2014.03.003. eCollection 2014 Jun.

14.

Optical coherence tomography in bioabsorbable stents: mechanism of vascular response and guidance of stent implantation.

Mattesini A, Pighi M, Konstantinidis N, Ghione M, Kilic D, Foin N, Dall'ara G, Secco GG, Valente S, Di Mario C.

Minerva Cardioangiol. 2014 Feb;62(1):71-82. Review.

PMID:
24500218
15.

[Role of bioresorbable scaffold and optical coherence tomography in the treatment of recurrent in-stent restenosis: a case report].

Mattesini A, Dall'Ara G, Rama-Merchan JC, Ghione M, Foin N, Secco GG, Di Mario C.

G Ital Cardiol (Rome). 2013 Dec;14(12):836-8. doi: 10.1714/1371.15241. Italian. No abstract available.

PMID:
24336600
16.

Tools & techniques clinical: optimising stenting strategy in bifurcation lesions with insights from in vitro bifurcation models.

Foin N, Mattesini A, Ghione M, Dall'ara G, Sen S, Nijjer S, Petraco R, Sgueglia GA, Davies JE, Di Mario C.

EuroIntervention. 2013 Nov;9(7):885-7. doi: 10.4244/EIJV9I7A144. No abstract available.

17.

Early coverage of Bioabsorbable Scaffold after STEMI analysed by 2D and 3D optical coherence tomography.

Foin N, Ghione M, Mattesini A, Dall'Ara G, Davies JE, Di Mario C.

Cardiovasc Revasc Med. 2013 Nov-Dec;14(6):363-4. doi: 10.1016/j.carrev.2013.08.002. Epub 2013 Sep 26. No abstract available.

PMID:
24075359
18.

Echocardiographic and clinical outcomes of central versus noncentral percutaneous edge-to-edge repair of degenerative mitral regurgitation.

Estévez-Loureiro R, Franzen O, Winter R, Sondergaard L, Jacobsen P, Cheung G, Moat N, Ihlemann N, Ghione M, Price S, Duncan A, Streit Rosenberg T, Barker S, Di Mario C, Settergren M.

J Am Coll Cardiol. 2013 Dec 24;62(25):2370-2377. doi: 10.1016/j.jacc.2013.05.093. Epub 2013 Sep 4.

19.

Bioabsorbable scaffold optimization in provisional stenting: insight from optical coherence tomography.

Foin N, Ghione M, Mattesini A, Davies JE, Di Mario C.

Eur Heart J Cardiovasc Imaging. 2013 Dec;14(12):1149. doi: 10.1093/ehjci/jet137. Epub 2013 Jul 24. No abstract available.

PMID:
23884966
20.

Tools and techniques - clinical: catheter compatibility in CTO recanalisation.

Ghione M, Agudo P, Kilickesmez K, Estevez-Loureiro R, Zivelonghi C, Lindsay A, Foin N, Secco GG, Di Mario C.

EuroIntervention. 2013 Jun 22;9(2):290-1. doi: 10.4244/EIJV9I2A46. No abstract available.

21.

Location of side branch access critically affects results in bifurcation stenting: Insights from bench modeling and computational flow simulation.

Foin N, Torii R, Alegria E, Sen S, Petraco R, Nijjer S, Ghione M, Davies JE, Di Mario C.

Int J Cardiol. 2013 Oct 9;168(4):3623-8. doi: 10.1016/j.ijcard.2013.05.036. Epub 2013 May 25.

PMID:
23714592
22.

Endovascular imaging and 3-dimensional reconstruction of spontaneous coronary artery dissection.

Cordone S, Ghione M, Foin N, Bacino L, Botta M, Bellotti P, Bellone P.

J Am Coll Cardiol. 2013 Jul 23;62(4):350. doi: 10.1016/j.jacc.2013.01.099. Epub 2013 May 21. No abstract available.

23.

Highlights from The Experts "Live", 4th annual congress of the Euro CTO Club, London 2012.

Di Mario C, Hildick-Smith D, Gershlick A, Ghione M, Agudo P, Alahmar A, Galassi A, Werner GS.

EuroIntervention. 2013 Apr 22;8(12):1359-61. doi: 10.4244/EIJV8I12A208. No abstract available.

24.

Intracoronary imaging using attenuation-compensated optical coherence tomography allows better visualisation of coronary artery diseases.

Foin N, Mari JM, Nijjer S, Sen S, Petraco R, Ghione M, Di Mario C, Davies JE, Girard MJ.

Cardiovasc Revasc Med. 2013 May-Jun;14(3):139-43. doi: 10.1016/j.carrev.2013.03.007. Epub 2013 Apr 28.

PMID:
23632229
25.

Increase in J-CTO lesion complexity score explains the disparity between recanalisation success and evolution of chronic total occlusion strategies: insights from a single-centre 10-year experience.

Syrseloudis D, Secco GG, Barrero EA, Lindsay AC, Ghione M, Kilickesmez K, Foin N, Martos R, Di Mario C.

Heart. 2013 Apr;99(7):474-9. doi: 10.1136/heartjnl-2012-303205. Epub 2013 Feb 2.

PMID:
23376946
26.

Sealing old plaques, seeding new plaques.

Ghione M, Kilickesmez K, Di Mario C.

Eur Heart J Cardiovasc Imaging. 2013 Mar;14(3):203-4. doi: 10.1093/ehjci/jes219. Epub 2012 Oct 24. No abstract available.

PMID:
23097008
27.

Malaric placentas. A quantitative study and clinico-pathological correlations.

Leopardi O, Naughten W, Salvia L, Colecchia M, Matteelli A, Zucchi A, Shein A, Muchi JA, Carosi G, Ghione M.

Pathol Res Pract. 1996 Sep;192(9):892-8; discussion 899-900.

PMID:
8950755
28.
29.
30.

Activity of bilobalide, a sesquiterpene from Ginkgo biloba, on Pneumocystis carinii.

Atzori C, Bruno A, Chichino G, Bombardelli E, Scaglia M, Ghione M.

Antimicrob Agents Chemother. 1993 Jul;37(7):1492-6.

31.

In vitro activity of pharmacological compounds carried by lipidic microparticles.

Taramelli D, Malabarba MG, Rossi P, Granucci C, Ghione M.

Pharmacol Res. 1992 Sep;26 Suppl 2:126-7. No abstract available.

PMID:
1409275
32.

Ocular pharmacokinetics of rufloxacin a new fluoroquinolone antibiotic.

Nucci P, Lombardo N, Cremonesi F, Manitto MP, Brancato R, Ghione M.

Clin Ter. 1992 Jun;140(6):563-7.

PMID:
1322259
33.

An anti-doxorubicin monoclonal antibody modulates kinetic and dynamic characteristics of the drug.

Sardini A, Villa E, Morelli D, Ghione M, Ménard S, Colnaghi MI, Balsari A.

Int J Cancer. 1992 Feb 20;50(4):617-20.

PMID:
1537626
34.

Anti-drug monoclonal antibodies antagonize toxic effect more than anti-tumor activity of doxorubicin.

Balsari A, Ménard S, Colnaghi MI, Ghione M.

Int J Cancer. 1991 Apr 1;47(6):889-92.

PMID:
2010231
35.

Antigen-specific immunodepression induced by doxorubicin-BSA conjugate in mice.

Balsari A, Cerofolini M, Ghione M.

Int J Immunopharmacol. 1991;13(2-3):155-8.

PMID:
2071292
36.

A new monoclonal antibody recognizing anthracyclinic molecule.

Balsari A, Morelli D, Menard S, Tagliabue E, Colnaghi MI, Ghione M.

Anticancer Res. 1990 Jan-Feb;10(1):129-32.

PMID:
1692196
37.

Skin and perivascular toxicity induced experimentally by doxorubicin.

Balsari A, Lombardo N, Ghione M.

J Chemother. 1989 Oct;1(5):324-9.

PMID:
2585034
38.

Humoral circulatory immune response to Gardnerella vaginalis.

Ghione M, Clerici PA, Piragine G, Magliano E.

J Clin Microbiol. 1989 Sep;27(9):2138-9.

39.

Monoclonal antibodies against doxorubicin.

Balsari A, Alzani R, Parrello D, Morelli D, Tagliabue E, Gianni L, Isetta AM, Menard S, Colnaghi MI, Ghione M.

Int J Cancer. 1988 Nov 15;42(5):798-802.

PMID:
3182109
40.

Usnic acid revisited, its activity on oral flora.

Ghione M, Parrello D, Grasso L.

Chemioterapia. 1988 Oct;7(5):302-5.

PMID:
2975969
41.

[Trichomonas vaginalis, epithelial cells, spermatozoa, and immunologic reactions. How and why an infection persists unchanged despite knowing an adequate drug therapy].

Granucci C, Rossi P, Sangiorgio ML, Falcone L, Ghione M.

G Ital Chemioter. 1988 Jan-Dec;35(1-3):75-81. Italian. No abstract available.

PMID:
3267183
42.

Antitumor drugs.

Ghione M.

Chemioterapia. 1987 Jun;6(2 Suppl):674-5. Review. No abstract available.

PMID:
3334659
43.

[Indirect immunofluorescence in the serodiagnosis of Trichomonas vaginalis infections].

Sangiorgio M, Barbuto Attiè MC, Granucci E, Ghione M.

Boll Ist Sieroter Milan. 1987;66(1):55-8. Italian.

PMID:
3304346
44.

Human fibroblast interferon in cervical and vulvar intraepithelial neoplasia associated with viral cytopathic effects. A pilot study.

De Palo G, Stefanon B, Rilke F, Pilotti S, Ghione M.

J Reprod Med. 1985 May;30(5):404-8.

PMID:
2989515
45.

[Characteristics of the immunomodulating action of bacterial and non-bacterial products].

Ghione M.

G Ital Chemioter. 1985 Jan-Apr;32(1):141-5. Italian. No abstract available.

PMID:
3830771
46.

Antibiotics in the chemotherapy of amebiasis.

Ghione M.

Chemioterapia. 1984 Dec;3(6):394-402.

PMID:
6099226
47.

The drug-immune system interaction in cancer therapy.

Ghione M.

Int J Tissue React. 1984;6(6):513-21.

PMID:
6530355
48.

Thymostimulin in malignant pleural effusions.

Rimoldi R, Brunetta F, Fioretti M, Bandera M, Ghione M.

Int J Tissue React. 1984;6(1):53-5.

PMID:
6201454
49.

Human fibroblast interferon in cervical and vulvar intraepithelial neoplasia associated with papilloma virus infection.

De Palo G, Stefanon B, Rilke F, Pilotti S, Ghione M.

Int J Tissue React. 1984;6(6):523-7.

PMID:
6099344
50.

Human polypeptidic hormone-like substances in microorganisms.

Ghione M, Dell'Orto P.

Microbiologica. 1983 Oct;6(4):315-26.

PMID:
6319976

Supplemental Content

Loading ...
Support Center